Cargando…
Erratum: Will PI3K pathway inhibitors be effective as single agents in patients with cancer?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122353/ https://www.ncbi.nlm.nih.gov/pubmed/30190795 http://dx.doi.org/10.18632/oncotarget.26017 |
| _version_ | 1783352638434181120 |
|---|---|
| author | Garrett, Joan T. Chakrabarty, Anindita Arteaga, Carlos L. |
| author_facet | Garrett, Joan T. Chakrabarty, Anindita Arteaga, Carlos L. |
| author_sort | Garrett, Joan T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6122353 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-61223532018-09-06 Erratum: Will PI3K pathway inhibitors be effective as single agents in patients with cancer? Garrett, Joan T. Chakrabarty, Anindita Arteaga, Carlos L. Oncotarget Erratum Impact Journals LLC 2018-08-17 /pmc/articles/PMC6122353/ /pubmed/30190795 http://dx.doi.org/10.18632/oncotarget.26017 Text en Copyright: © 2018 Garrett et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
| spellingShingle | Erratum Garrett, Joan T. Chakrabarty, Anindita Arteaga, Carlos L. Erratum: Will PI3K pathway inhibitors be effective as single agents in patients with cancer? |
| title | Erratum: Will PI3K pathway inhibitors be effective as single agents in patients with cancer? |
| title_full | Erratum: Will PI3K pathway inhibitors be effective as single agents in patients with cancer? |
| title_fullStr | Erratum: Will PI3K pathway inhibitors be effective as single agents in patients with cancer? |
| title_full_unstemmed | Erratum: Will PI3K pathway inhibitors be effective as single agents in patients with cancer? |
| title_short | Erratum: Will PI3K pathway inhibitors be effective as single agents in patients with cancer? |
| title_sort | erratum: will pi3k pathway inhibitors be effective as single agents in patients with cancer? |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122353/ https://www.ncbi.nlm.nih.gov/pubmed/30190795 http://dx.doi.org/10.18632/oncotarget.26017 |
| work_keys_str_mv | AT garrettjoant erratumwillpi3kpathwayinhibitorsbeeffectiveassingleagentsinpatientswithcancer AT chakrabartyanindita erratumwillpi3kpathwayinhibitorsbeeffectiveassingleagentsinpatientswithcancer AT arteagacarlosl erratumwillpi3kpathwayinhibitorsbeeffectiveassingleagentsinpatientswithcancer |